Indiva Limited

NDVA

CA45580J1012

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 12:17:26 18/05/2024 am IST			5-day change	1st Jan Change
0.065 ^CAD	0.00%		0.00%	-31.58%

25/04	Transcript : Indiva Limited, Q4 2023 Earnings Call, Apr 25, 2024
25/04	Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024	CI

Indiva Limited Approves Election of Niel Marotta as Director

June 27, 2019 at 05:32 am IST

Indiva Limited announced at the annual general and special meeting of shareholders has approved the election of Niel Marotta as director.

Latest news about Indiva Limited

Transcript : Indiva Limited, Q4 2023 Earnings Call, Apr 25, 2024	25/04
Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024	25/04	CI
Indiva Limited Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Indiva Limited cancelled the transaction announced on February 28, 2024	04/03	CI
Indiva Files Amended And Restated Offering Document And Announced Concurrent Private Placement Of Up To $4.3 Million	28/02	MT
Indiva Limited announced that it expects to receive CAD 4.312 million in funding	28/02	CI
Indiva Announces Private Placement Under The Listed Issuer Financing Exemption of Up To $4 Million	22/01	MT
Indiva Limited announced that it expects to receive CAD 4 million in funding	22/01	CI
Indiva Updates Q4 Revenue Guidance; Provides 2023 Highlights	04/01	MT
Indiva Limited Revises Revenue Guidance for the Fourth Quarter of 2023	04/01	CI
Indiva Narrows Q3 Loss, Revenue Rises; Provides Q4 Outlook	21/11	MT
Transcript : Indiva Limited, Q3 2023 Earnings Call, Nov 21, 2023	21/11
Indiva Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Indiva Limited Provides Revenue Guidance for Fourth Quarter of 2023	21/11	CI
Indiva Limited Announces the Revenue Guidance for Third Quarter of 2023	29/23/29	CI
Indiva Posts Q2 Net Loss, Revenue Declines YOY	29/23/29	MT
Transcript : Indiva Limited, Q2 2023 Earnings Call, Aug 29, 2023	29/23/29
Indiva Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Indiva Limited Launches No Future Gummies and Vapes	10/23/10	CI
Transcript : Indiva Limited - Shareholder/Analyst Call	19/23/19
Indiva Brief: SNDL Inc. Says Between June 10, 2023, and June 22, 2023, It Disposed of 3,297,000 Common Shares In the Capital of Indiva	22/23/22	MT
Canopy Growth and Indiva Brief: Announcing Closing of Private Placement	17/23/17	MT
Indiva Limited announced that it has received CAD 2.155617 million in funding from Canopy Growth Corporation	16/23/16	CI
SNDL Cuts Stake in Indiva	12/23/12	MT
Canopy Growth and Indiva Detail Agreement Related To Wana Brands; Transaction Terms Given	30/23/30	MT

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its products include edibles and capsules. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, Fudge Double-Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. It sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound.

Sector

Pharmaceuticals

Calendar

23/05/2024 - Q1 2024 Earnings Release

More about the company

	1st Jan change	Capi.
INDIVA LIMITED	-31.58%	93.39L
DONG-E-E-JIAO CO.,LTD.	+42.38%	626.15Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.86%	449.03Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.36%	328.56Cr
TASLY PHARMACEUTICAL GROUP CO., LTD	-11.28%	312.36Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.23%	249.68Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.24%	194.05Cr
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	168.5Cr
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.98%	163.49Cr
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-11.32%	156.41Cr

Alternative Medicine

Indiva Limited

Equities

NDVA

CA45580J1012

Pharmaceuticals

Indiva Limited Approves Election of Niel Marotta as Director

Latest news about Indiva Limited

Chart Indiva Limited

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Alternative Medicine